Lori Macomber
Net worth: 800 838 $ as of 27/02/2026
Net worth: 800 838 $ as of 27/02/2026
Lori Macomber currently works at Karyopharm Therapeutics, Inc., as Chief Financial Officer, Treasurer & Executive VP from 2025.
Ms. Macomber also formerly worked at AMETEK, Inc., as Business Unit Controller from 2018 to 2019, Eli Lilly & Co., as Assistant VP-Finance Site Leader from 2010 to 2017, Cello Health Ltd., as Controller & Chief Financial Officer-US Region from 2017 to 2018, and Legend Biotech Corp., as Chief Financial Officer from 2022 to 2025.
Ms. Macomber received her undergraduate degree from The Pennsylvania State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/02/2026 | 85,105 ( 0.46% ) | 800 838 $ | 27/02/2026 |
| Companies | Position | Start |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Director of Finance/CFO | 02/01/2025 |
| Companies | Position | End |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Director of Finance/CFO | 01/01/2025 |
| AMETEK, INC. | Corporate Officer/Principal | 31/08/2019 |
| CELLO HEALTH PLC | Comptroller/Controller/Auditor | 31/01/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 31/03/2017 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
AMETEK, Inc.
AMETEK, Inc. Electrical ProductsProducer Manufacturing Manufactures and supplies electronic instruments and electromechanical devices | Producer Manufacturing |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Cello Health Ltd.
Cello Health Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company whose subsidiaries provides market research and consulting services | Commercial Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition